A comparative study on efficacy, safety and cost effectiveness analysis between vortioxetine and escitalopram in major depressive disorder
SA Pharmaceutical Journal · 01.04.2026 · 93 (2)
DOI: 10.36303/sapj.3549 ↗Kurz gefasst
Fachartikel in der Zeitschrift SA Pharmaceutical Journal, erschienen am 01.04.2026. Verfasst von VS Vaishnavi und 5 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Vaishnavi, V., Kumar, T. P., Valluru, R., Syamala, Y., Siva, C., & Bhavana, R. (2026). A comparative study on efficacy, safety and cost effectiveness analysis between vortioxetine and escitalopram in major depressive disorder. SA Pharmaceutical Journal, 93(2). https://doi.org/10.36303/sapj.3549
Vancouver
Vaishnavi V, Kumar TP, Valluru R, Syamala Y, Siva C, Bhavana R. A comparative study on efficacy, safety and cost effectiveness analysis between vortioxetine and escitalopram in major depressive disorder. SA Pharmaceutical Journal. 2026;93(2). doi:10.36303/sapj.3549
BibTeX
@article{Vaishnavi2026,
author = {Vaishnavi, VS and Kumar, TV Pavan and Valluru, R and Syamala, Y and Siva, C and Bhavana, R},
title = {A comparative study on efficacy, safety and cost effectiveness analysis between vortioxetine and escitalopram in major depressive disorder},
journal = {SA Pharmaceutical Journal},
year = {2026},
volume = {93},
number = {2},
doi = {10.36303/sapj.3549}
}
EUVIMED